Skip to main
AMAM
AMAM logo

AMAM Earnings Dates & Reports

AMAM Most Recent Earnings

Report DateNov 13, 2023
Period EndingQ3 2023
Est. EPS-$0.09
Actual EPS-$0.37
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

AMAM Earnings per Share (EPS) History

Signup for full access
Browse free

AMAM Latest Earnings

The value each AMAM share was expected to gain vs. the value each share gained.

AMAM reported its most recent earnings on Nov 13, 2023 for Q3 2023, posting earnings per share (EPS) of -$0.37. This exceeded analysts' expectations of -$0.09 by 311.11%, marking a Miss.

For comparison, Ambrx Biopharma Inc reported EPS of $0 in the same quarter last year.

The company is expected to announce its next earnings report on 11/13/2023, with analysts projecting an EPS of $0.

AMAM Earnings History

Earnings
Est. EPSActual EPSSurprise
Q3 2023Nov 13, 2023
-$0.09-$0.37+311.11%
DeckReportListen
Q2 2023Aug 9, 2023
-$0.09-$0.35+288.89%
DeckReportListen
Q1 2023May 11, 2023
-$0.05
DeckReportListen

AMAM Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Ambrx Biopharma Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Aug 9, 2023
May 11, 2023

AMAM Earnings FAQs

AMAM last reported earnings on Nov 13, 2023 for Q3 2023, posting an EPS of -$0.37, which Miss the estimate of -$0.09 by 311.11%.

For Q3 2023, AMAM reported an EPS of -$0.37, missing analysts' estimate of -$0.09 by 311.11%.

For Q3 2023, AMAM Miss expectations with an actual EPS of -$0.37 vs. an estimated EPS of -$0.09.

Following the last earnings report on Nov 13, 2023, AMAM's stock price moved — from — to —.

The next AMAM earnings call is scheduled for Nov. 13, 2023, where executives will discuss financial results and outlook.

Ambrx Biopharma Inc (AMAM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.